Cargando…
Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593964/ https://www.ncbi.nlm.nih.gov/pubmed/30666809 http://dx.doi.org/10.1002/art.40805 |
| _version_ | 1783430161257988096 |
|---|---|
| author | Meesilpavikkai, Kornvalee Dik, Willem A. Schrijver, Benjamin van Helden‐Meeuwsen, Cornelia G. Versnel, Marjan A. van Hagen, P. Martin Bijlsma, Emilia K. Ruivenkamp, Claudia A. L. Oele, Margreet J. Dalm, Virgil A. S. H. |
| author_facet | Meesilpavikkai, Kornvalee Dik, Willem A. Schrijver, Benjamin van Helden‐Meeuwsen, Cornelia G. Versnel, Marjan A. van Hagen, P. Martin Bijlsma, Emilia K. Ruivenkamp, Claudia A. L. Oele, Margreet J. Dalm, Virgil A. S. H. |
| author_sort | Meesilpavikkai, Kornvalee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6593964 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-65939642019-07-10 Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy Meesilpavikkai, Kornvalee Dik, Willem A. Schrijver, Benjamin van Helden‐Meeuwsen, Cornelia G. Versnel, Marjan A. van Hagen, P. Martin Bijlsma, Emilia K. Ruivenkamp, Claudia A. L. Oele, Margreet J. Dalm, Virgil A. S. H. Arthritis Rheumatol Concise Communication John Wiley and Sons Inc. 2019-03-06 2019-05 /pmc/articles/PMC6593964/ /pubmed/30666809 http://dx.doi.org/10.1002/art.40805 Text en © 2019 The Authors. Arthritis & Rheumatology published by Wiley Periodicals, Inc. on behalf of American College of Rheumatology. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Concise Communication Meesilpavikkai, Kornvalee Dik, Willem A. Schrijver, Benjamin van Helden‐Meeuwsen, Cornelia G. Versnel, Marjan A. van Hagen, P. Martin Bijlsma, Emilia K. Ruivenkamp, Claudia A. L. Oele, Margreet J. Dalm, Virgil A. S. H. Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy |
| title | Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy |
| title_full | Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy |
| title_fullStr | Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy |
| title_full_unstemmed | Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy |
| title_short | Efficacy of Baricitinib in the Treatment of Chilblains Associated With Aicardi‐Goutières Syndrome, a Type I Interferonopathy |
| title_sort | efficacy of baricitinib in the treatment of chilblains associated with aicardi‐goutières syndrome, a type i interferonopathy |
| topic | Concise Communication |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6593964/ https://www.ncbi.nlm.nih.gov/pubmed/30666809 http://dx.doi.org/10.1002/art.40805 |
| work_keys_str_mv | AT meesilpavikkaikornvalee efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT dikwillema efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT schrijverbenjamin efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT vanheldenmeeuwsencorneliag efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT versnelmarjana efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT vanhagenpmartin efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT bijlsmaemiliak efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT ruivenkampclaudiaal efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT oelemargreetj efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy AT dalmvirgilash efficacyofbaricitinibinthetreatmentofchilblainsassociatedwithaicardigoutieressyndromeatypeiinterferonopathy |